Vol 2016, No 3 (2016)

Table of Contents

Licensing

Baxter’s Foray Into CAR-T Cell Therapy With a Deal Worth US$ 1.7 B Abstract pdf html
Taskin Ahmed & Rohit Khera
AbbVie adds Boehringer Ingelheim’s BI 655066 to its Autoimmune Portfolio Abstract pdf html
Natasha Berry
Exelixis Partners its Oncology Drug Cabozantinib with Ipsen for US$200 M Upfront Abstract pdf html
Heather Cartwright & Jasmine Kalsi

Mergers & Acquisitions

Acorda Boosts Parkinson’s Disease Franchise with US$363 M Acquisition of Biotie Abstract pdf html
Heather Cartwright & Sayani Datta

Opinion & Analysis

IMS PharmaDeals Review of 2015 Abstract pdf
Heather Cartwright & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.